The future of scientific discovery is shaped by the questions researchers choose to pursue today.
Founding Director of the Duncan Neurological Research Institute (Duncan NRI), Dr. Huda Zoghbi brought that perspective to Revolutions in Science: Discovery, Imagination, and the Future, a national symposium co-hosted by the National Academy of Sciences and the Smithsonian Institution. The event commemorated America’s 250th anniversary and challenged researchers to consider the discoveries that could define the next 250 years of science.
During the symposium, Dr. Zoghbi discussed how current scientific challenges intersect with emerging opportunities to advance human health, contributing to the broader dialogue on how fundamental research informs the future of medicine. She emphasized that meaningful discovery begins with asking bold questions that push beyond current understanding to reveal new paths toward breakthroughs in science.
Her research reflects that philosophy. From uncovering the genetic basis of Rett syndrome to identifying tau regulators that guide new therapeutic approaches for neurodegeneration, Dr. Zoghbi demonstrates how foundational inquiry reshapes understanding of neurological disease and expands treatment options.
Dr. Zoghbi also leads the Duncan NRI team with that same spirit, fostering a research environment grounded in curiosity and collaboration. The team applies this rigorous approach across a wide range of studies, turning complex biological mysteries into actionable insights.
By bridging the gap between today’s laboratory discoveries and tomorrow’s clinical reality, Dr. Zoghbi and the Duncan NRI team are driving discoveries that bring life-changing hope to patients and families around the world.